Jonathan McNeal, DO
Neurological Surgery · Roanoke, VANPI 1164670345
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,978 of the $6,889 with a category attached, or 72.3%. Nevro Corp. accounts for 87.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $6,001 and has fallen 97.0% since, to $181 in 2025.
Across 49 payments — averaging $140.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$6K
- Medtronic$175
- Boston Scientific$140
- Kuros Biosciences USA, Inc$105
- Johnson & Johnson$105
- Abbott$86
- plus $248 from 6 others
What the payments were for
- Travel & lodging$67710%
- Food & beverage$1,23418%
- Education$4,97872%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 17 | $6,031 |
| Medtronic | 5 | $175 |
| Boston Scientific | 3 | $140 |
| Kuros Biosciences USA, Inc | 2 | $105 |
| Johnson & Johnson(2 entities) | 5 | $105 |
| Abbott | 4 | $86 |
| Providence Medical Technology, Inc. | 4 | $80 |
| Ossur Americas, Inc. | 2 | $42 |
| Orthofix Medical, Inc. | 4 | $41 |
| UCB, Inc. | 1 | $36 |
| Stryker | 1 | $31 |
| AstraZeneca | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$5,604
How this compares
$6,889 in reported general payments places this provider in the 70th percentile of 156 neurological surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 135 | $1,074 |
| Methocarbamol | 119 | $810 |
| Gabapentin | 37 | $260 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $136 |
| Tramadol Hcl | 30 | $132 |
| Meloxicam | 30 | $58 |
| Diazepam | 29 | $34 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Roanoke
- Gary SimondsRoanoke$13K
- Eric MarvinRoanoke$12K
- John EntwistleRoanoke$11K
- Sandeep MittalRoanoke$9K
- Greg HowesRoanoke$5K
- Mark WitcherRoanoke$4K
- Justin SmithCharlottesville$2.3M
- David VincentVirginia Beach$959K
- Mudit SharmaManassas$714K
- Ryan KelloggCharlottesville$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.